{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR295/080/SRR29525080/SRR29525080_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR295/076/SRR29525076/SRR29525076_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR295/078/SRR29525078/SRR29525078_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR295/077/SRR29525077/SRR29525077_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR295/076/SRR29525076/SRR29525076_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR295/079/SRR29525079/SRR29525079_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR295/079/SRR29525079/SRR29525079_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR295/075/SRR29525075/SRR29525075_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR295/077/SRR29525077/SRR29525077_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR295/078/SRR29525078/SRR29525078_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR295/075/SRR29525075/SRR29525075_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR295/080/SRR29525080/SRR29525080_1.fastq.gz"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["yangzhou university"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA1127666"],"scientific_name":["Homo sapiens"],"tag":["xref:PubMed:39667501"],"long_description":["Via analyzing the expression matrix of palbociclib-sensitive and palbociclib-resistant tumors from patients with breast cancer, it was revealed that NSRP1 is associated with CDK4/6i resistance. Therefore, RNA Sequencing is performed for MCF7 cells transfected with ctr or NSRP1 siRNA to study the molecular mechanism of NSRP1 in mediating CDK4/6i resistance in breast cancer cells. Overall design: We transfected MCF7 cells with NSRP1 siRNAs or control siRNA."],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"Downregulation of NSRP1 confers CDK4/6i resistance in breast cancer via activation of the IFN signaling pathway","description":"Downregulation of NSRP1 confers CDK4/6i resistance in breast cancer via activation of the IFN signaling pathway","dates":{"last_updated":"2025-09-24","first_public":"2025-01-31"},"accession":"PRJNA1127666","cross_references":{"GEO":["GSE270673"],"taxon":["9606"],"PubMed":["39667501"]}}